Charles River Laboratories Intl. Inc vs Honeywell International Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B), while Honeywell International Inc trades at $230.4 (market cap $72.93B). The key difference: Honeywell International Inc is far larger — about 5.4× Charles River Laboratories Intl. Inc's market cap, and Honeywell International Inc pays a 1.22% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | HON | |
|---|---|---|
Market Cap | $13.46B | $72.93B |
Sector | Health | Industrials |
52-Week High | $282.00 | $248.79 |
52-Week Low | $145.57 | $188.14 |
Enterprise Value | $16.30B | $97.73B |
Dividend Yield | — | 1.22% |
Trailing returns across standard periods
Latest headlines on both assets
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →